Your browser doesn't support javascript.
loading
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.
Chen, Qitong; Ouyang, Dengjie; Anwar, Munawar; Xie, Ning; Wang, Shouman; Fan, Peizhi; Qian, Liyuan; Chen, Gannong; Zhou, Enxiang; Guo, Lei; Gu, Xiaowen; Ding, Boni; Yang, Xiaohong; Liu, Liping; Deng, Chao; Xiao, Zhi; Li, Jing; Wang, Yunqi; Zeng, Shan; Hu, Jinhui; Zhou, Wei; Qiu, Bo; Wang, Zhongming; Weng, Jie; Liu, Mingwen; Li, Yi; Tang, Tiegang; Wang, Jianguo; Zhang, Hui; Dai, Bin; Tang, Wuping; Wu, Tao; Xiao, Maoliang; Li, Xiantao; Liu, Hailong; Li, Lai; Yi, Wenjun; Ouyang, Quchang.
Afiliação
  • Chen Q; Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Ouyang D; Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Anwar M; Department of General Surgery, Xiangya Hospital Central South University, Changsha, China.
  • Xie N; Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Wang S; Department of Breast Internal Medicine, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Fan P; Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, China.
  • Qian L; Department of Breast and Thyroid Surgery, Hunan Provincial People's Hospital, Changsha, China.
  • Chen G; Department of Breast and Thyroid Surgery, Central South University Third Xiangya Hospital, Changsha, China.
  • Zhou E; Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Guo L; Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Gu X; Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, China.
  • Ding B; Department of Breast and Thyroid Surgery, Hunan Provincial People's Hospital, Changsha, China.
  • Yang X; Department of Breast and Thyroid Surgery, Central South University Third Xiangya Hospital, Changsha, China.
  • Liu L; Department of Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Cental South University, Changsha, China.
  • Deng C; Department of Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Cental South University, Changsha, China.
  • Xiao Z; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Li J; Department of Breast Internal Medicine, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Wang Y; Department of Breast Medical Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Cental South University, Changsha, China.
  • Zeng S; Department of Traditional Chinese Medicine, The Affiliated Cancer Hospital of Xiangya School of Medicine, Cental South University, Changsha, China.
  • Hu J; Department of Internal Medicine - Oncology, Xiangya Hospital Central South University, Changsha, China.
  • Zhou W; Department of Breast Surgery, The First Hospital Hunan University of Chinese Medicine, Changsha, China.
  • Qiu B; Department of Breast and Thyroid Surgery, The Affiliated ZhuZhou Hospital of Xiangya School of Medicine Central South University, Zhuzhou, China.
  • Wang Z; Department of Oncology, The Affiliated ZhuZhou Hospital of Xiangya School of Medicine Central South University, Zhuzhou, China.
  • Weng J; Department of Breast Surgery, The Third People's Hospital of Yongzhou, Yongzhou, China.
  • Liu M; Department of Oncology, The First People's Hospital of Yueyang, Yueyang, China.
  • Li Y; Department of Breast and Thyroid Surgery, The First People's Hospital of Xiangtan City, Xiangtan, China.
  • Tang T; Department of Oncology, The Third People's Hospital of Changde, Changde, China.
  • Wang J; Department of Oncology, Xiangtan Central Hospital, Xiangtan, China.
  • Zhang H; Department of General Surgery, Xiangtan Central Hospital, Xiangtan, China.
  • Dai B; Department of Oncology, Central Hospital of Shaoyang, Shaoyang, China.
  • Tang W; Department of Breast and Thyroid Surgery, Central Hospital of Shaoyang, Shaoyang, China.
  • Wu T; Department of Breast Surgery, Shaoyang Hospital of Traditional Chinese Medicine, Shaoyang, China.
  • Xiao M; Department of Oncology, The First People's Hospital of Changde, Changde, China.
  • Li X; Department of Oncology, The Third Hospital of Hunan University of Chinese Medicine, Zhuzhou, China.
  • Liu H; Department of Oncology, The Central Hospital of Yiyang, Yiyang, China.
  • Li L; Department of Internal Medicine - Oncology, The First People's Hospital of Chenzhou, Chenzhou, China.
  • Yi W; Department of Breast and Thyroid Surgery, The People's Hospital of Xiangtan County, Xiangtan, China.
  • Ouyang Q; Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Front Oncol ; 11: 661128, 2021.
Article em En | MEDLINE | ID: mdl-33747972
ABSTRACT
[This corrects the article DOI 10.3389/fonc.2020.00811.].
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China